DNAzyme-Powered DNA Walker for Cooperative Expression Imaging of Mutant p53 and Telomerase in Cancer Cells

Anal Chem. 2023 Feb 28;95(8):4122-4130. doi: 10.1021/acs.analchem.2c05111. Epub 2023 Feb 17.

Abstract

Cooperative expression of multiple cancer biomarkers is of great significance in influencing cell pathways and drug treatment. However, the simultaneous analysis of low-abundance biomarkers in living cells remains a challenge. Here, we report a DNAzyme-powered DNA walker to visualize the cooperative expression of mutant p53 and telomerase in living cells. The activation of the DNA walker is orthogonally powered by mutated p53 and telomerase, which enables the unlocking of the walking strand and the subsequently repeated substrate cleavage, producing fluorescence recovery for the imaging of the two target molecules in living cells. The DNA walker allows for real-time monitoring of the expression profile of mutant p53 and active telomerase in cancer cells under various antitumor drug treatments, and the results demonstrate the cooperative expression of mutant p53 and telomerase via the Akt pathway, which may bring new insights into the study of cancer pathway-relevant biomarkers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA / chemistry
  • DNA, Catalytic* / chemistry
  • Humans
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Telomerase* / metabolism
  • Tumor Suppressor Protein p53 / genetics

Substances

  • DNA, Catalytic
  • Tumor Suppressor Protein p53
  • Telomerase
  • DNA